Example: confidence

Echocardiographic Final Report - sononet.us

Name:DOB:Age:Date: Echocardiographic Final Report901 West 43rd St. Telephone: 816-569-2200 Kansas City, MO 64111 Fax: 816-581-2090AV Peak Vel:Location:Sonographer:Ht:Wt:2D/Dopple r Measurements:Indicatons:LVOT Peak VelFinal 2D Interpretation:cm/s (100-170)Ordering Physician:Sex:cm/s (80-120) Final Doppler Interpretation:Follow Up Recommendations:LVOT DiameterAV Area:cm ( )cm( :Est. EF:PAP:mmHg(>55%)LAs:LVd:LVs:IVS:LVPWMV Peak Vel:TV Peak Vel:PV Peak Vel:cm( )cm( )cm( )cm( )cm( )cm/s(60-130)cm/s(30-70)cm/s(60-90 AOcm ( )RVdcm( )LA V I< 29 ml/m2 PVRPVaE/ E PrimeE Prime Vel(<30)(<8)Hemodynamic AnalysisHR:bpm(60-100 Stroke Vol:cc(50-90) Cardiac Out:l/min(4-7)CI:l/min/m ( )BSA:LVOT VTIS impsons EF:(>55%)LA VBP/(>10 )CARDIOLOGISTICAEL & ICAVL AccreditedAV VTI SAMPLE, PATIENT06/19/195903/07/2011 13:3851 Reading Physician MD FACC onset of Congestive Heart Failure, Idiopathic/Constrictive/Restrictive, Cardiac Dysrhytmia, unspecified, Tachycardia, Shortness of Breath, Tobacco Use Disorder, Morb)))

Name: DOB: Age: Date: Echocardiographic Final Report 901 West 43rd St. Telephone: 816-569-2200 Kansas City, MO 64111 www.sononet.us Fax: 816-581-2090

Tags:

  Echocardiographic

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of Echocardiographic Final Report - sononet.us

1 Name:DOB:Age:Date: Echocardiographic Final Report901 West 43rd St. Telephone: 816-569-2200 Kansas City, MO 64111 Fax: 816-581-2090AV Peak Vel:Location:Sonographer:Ht:Wt:2D/Dopple r Measurements:Indicatons:LVOT Peak VelFinal 2D Interpretation:cm/s (100-170)Ordering Physician:Sex:cm/s (80-120) Final Doppler Interpretation:Follow Up Recommendations:LVOT DiameterAV Area:cm ( )cm( :Est. EF:PAP:mmHg(>55%)LAs:LVd:LVs:IVS:LVPWMV Peak Vel:TV Peak Vel:PV Peak Vel:cm( )cm( )cm( )cm( )cm( )cm/s(60-130)cm/s(30-70)cm/s(60-90 AOcm ( )RVdcm( )LA V I< 29 ml/m2 PVRPVaE/ E PrimeE Prime Vel(<30)(<8)Hemodynamic AnalysisHR:bpm(60-100 Stroke Vol:cc(50-90) Cardiac Out:l/min(4-7)CI:l/min/m ( )BSA:LVOT VTIS impsons EF:(>55%)LA VBP/(>10 )CARDIOLOGISTICAEL & ICAVL AccreditedAV VTI SAMPLE, PATIENT06/19/195903/07/2011 13:3851 Reading Physician MD FACC onset of Congestive Heart Failure, Idiopathic/Constrictive/Restrictive, Cardiac Dysrhytmia, unspecified, Tachycardia, Shortness of Breath, Tobacco Use Disorder, Morbid left atrial enlargement.)))

2 Right atrial enlargement. The aortic valve is not well seen, cusp number is indeterminate, is sclerotic, butappears to open well. Mild mitral valve thickening. Structurally normal pulmonary and tricuspid valves. Dilated inferior vena cava ( ) with little or no respiratory collapse (<50%), consistent with elevated mean right atrial pressure. Normal aortic root and ascendingaorta dimensions. No intracardiac mass or thrombus. No pericardial significant valvular stenosis. No significant valvular regurgitation. Trivial mitral valve regurgitation. No evidence for shunt by colorDoppler FINDINGS: Systolic and diastolic congestive heart failure. Dilated left ventricle with severe diastolic dysfunction and reducedsystolic function. Tachycardia was noted during exam (118 bpm).

3 FINDINGS:1. Severe Diastolic Dysfunction: Moderate elevation of resting filling pressure. Severe increase in left atrial volume consistent with a historyof elevated LV filling Systolic Dysfunction: Mildly reduced LVEF 40%; Dilated left ventricle; Mild LV hypertrophy. Ill-defined regional wall motionabnormalities suggestive of possible resting ischemic heart Aortic valve sclerosis, a marker of atherosclerotic cardiovascular risk and future risk for MI, CVA, CHF and aortic Unable to estimate pulmonary artery systolic pressure. Normal RV size with reduced systolci function. Dilated IVC with reducedrespiratory INFORMATION:1. Further cardiovascular attention may be indicated. Cannot exclude coronary artery disease. 2. Considerations: Aggressive physiologic optimization irrespective of BP; normalization of resting LV filling pressure.

4 Highest tolerabledose ARB or ACEI; calcium channel blocker (dihydropyridine class); thiazide-like diuretic; Statin with a goal of LDL cholesterol <70mg/dl;non-selective Extreme Obesity (BMI: 46) is associated with severely increased risk of Cancer, Coronary Artery Disease, Type II Diabetes Follow-up: Echo/Doppler to assist in management of CV dysfunction in 1 year or sooner is appropriate if there is a documented change inclinical status or LOCATIONS ample Sonographer, RDCS,RVT,RDMSMD, Doctor 999-999-99991 year, If clinically indicatedF


Related search queries